🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04936620
Recruiting Not applicable

Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

NCT04936620 · tracked via the Priya Life Science Germany tracker
Sponsor
St George's, University of London
Phase
Not applicable
Started
2021-10-08
Last updated
2026-07-06

Condition(s) studied

Spinal Cord Injuries

Investigational drug(s) / intervention(s)

DuroplastySpinal surgery

Duroplasty: Expansion Duroplasty

Spinal surgery: Spinal surgery including laminectomy

Study summary

QUESTION. Does duroplasty improve outcome after spinal cord injury?

WHAT DO WE STUDY? We will investigate whether performing a surgical procedure called duroplasty improves outcomes after spinal cord injury.

WHY SPINAL CORD INJURY? Spinal cord injury is a devastating condition that causes permanent disability such as paralysis, numbness and loss of bladder and bowel control. Currently, there are no treatments shown to improve outcome after spinal cord injury.

WHAT IS DUROPLASTY? Duroplasty is an operation that involves opening the tough membrane around the cord, called the dura, and stitching a patch of artificial dura to expand the space around the swollen cord.

WHY IS DUROPLASTY BEING STUDIED? Based on our preliminary evidence, we think that the dura causes cord pressure after injury. We have shown in a small study of patients that performing this operation safely and effectively reduces pressure on the injured cord.

WHO IS ELIGIBLE? Adult patients with severe spinal cord injuries in the neck who will have surgery within 72 hours.

WHAT TREATMENT? Those who agree to take part will be allocated by chance (like tossing a coin) to standard treatment or standard treatment plus duroplasty. Some patients will also be asked to take part in a smaller study that involves placing probes at the injury site.

WHERE? Initially, we will recruit patients from U.K. Major Trauma Centres. Most assessments will be done in U.K. Spinal Injury Centres. Later on, we we also started recruiting from overseas.

HOW LONG? We aim to recruit 222 - 260 patients over 4 years. Patients will be followed up for a year.

WHAT DO WE ASSESS? Patients will be assessed (using questionnaires and by examination) how well they can use their hands, walk, control their bladder and bowel and their quality of life. Some of these assessments will be repeated at 3, 6 and 12 months after surgery.

WHAT IS THE OPTIONAL MECHANISTIC STUDY? DISCUS includes an optional study for at least 50 patients who will take part in the randomised controlled trial. The aim of the mechanistic study is to determine how duroplasty improves outcome, i.e. whether duroplasty reduces cord compression, improves blood flow to the injured cord perfusion, improves cord metabolism and reduces cord inflammation.

WHAT IS THE OPTIONAL INFORMATION STUDY? For the first two years, a study called QuinteT Recruitment Intervention (QRI) is designed to optimise patient recruitment and informed consent in the trauma setting.

Eligibility

Sex
ALL
Min age
16 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥16 years 2. Severe cervical (C2 - T1) traumatic spinal cord injury (AIS grade A-C) 3. Deemed to require and be suitable for surgery that includes laminectomy by local surgeon 4. Surgery within 72 hours of traumatic spinal cord injury 5. Able to provide informed consent or consultee declaration or proxy consent. Exclusion Criteria: 1. Dural tear due to traumatic spinal cord injury 2. Life-limiting or rehabilitation-restricting co-morbidities 3. Thoracic or lumbar traumatic spinal cord injury 4. Other central nervous system disease

Primary outcome measure(s)

Trial sites (34)

FacilityCityRegionStatus
Universität Klinik für Neurochirurgie Innsbruck Austria Recruiting
Kepler University Hospital Linz Austria Recruiting
University Hospital Salzburg Salzburg Austria Recruiting
St Polten University Hospital Sankt Pölten Austria Recruiting
UZ Leuven Leuven Belgium Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei Recruiting
Masaryk Hospital Ústí nad Labem Czechia Recruiting
Aarhus University Hospital Aarhus Denmark Recruiting
Kuopio University Hospital Kuopio Finland Recruiting
BG Unfallklinik Frankfurt am Main Frankfurt Germany Recruiting
Klinik und Poliklinik für Neurochirurgie Universitätsklinikum Frankfurt, 60596 FRANKFURT AM MAIN Frankfurt Germany Recruiting
Hadassah Medical Center Jerusalem Israel Recruiting
Shaare Zedek Medical Centre Jerusalem Israel Recruiting
University Medical Centre Ljubljana Ljubljana Slovenia Recruiting
12 de Octubre University Hospital Madrid Spain Recruiting
Skåne University Hospital Lund Sweden Recruiting
National Spinal Injuries Centre Aylesbury United Kingdom Active Not Recruiting
Queen Elizabeth Hospital Birmingham Birmingham United Kingdom Recruiting
Addenbrooke's Hospital Cambridge United Kingdom Recruiting
Royal Infirmary of Edinburgh Edinburgh United Kingdom Recruiting
Queen Elizabeth University Hospital Glasgow United Kingdom Recruiting
Hull Royal Infirmary Hull United Kingdom Recruiting
Leeds General Infirmary Leeds United Kingdom Recruiting
The Walton Centre Liverpool United Kingdom Recruiting
St George's Hospital London United Kingdom Recruiting
St Mary's Hospital London United Kingdom Recruiting
The London Spinal Cord Injury Centre London United Kingdom Active Not Recruiting
The Royal London Hospital London United Kingdom Recruiting
Queen's Medical Centre Nottingham United Kingdom Recruiting
Midlands Centre for Spinal Injuries, Oswestry United Kingdom Active Not Recruiting
Salford Royal Salford United Kingdom Recruiting
Sheffield Teaching Hospitals NHS Foundation Trust Sheffield United Kingdom Recruiting
North West Regional Spinal Injuries Centre Southport United Kingdom Active Not Recruiting
Pinderfields Hospital Wakefield United Kingdom Active Not Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04936620 on ClinicalTrials.gov ↗ ← All trials in Germany